Digital Content 
NEWS #PharmaBuzz
09 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/09/3095723/0/en/Sagimet-Biosciences-to-Host-Virtual-KOL-Event-A-New-Mechanism-of-Action-in-Treating-Acne-Update-on-Positive-Phase-3-Denifanstat-Trial-for-the-Treatment-of-Moderate-to-Severe-Acne-o.html
05 Jun 2025
// INVESTING
https://in.investing.com/news/stock-market-news/sagimet-biosciences-shares-soar-on-positive-acne-treatment-trial-results-93CH-4862187
03 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ascletis-announces-phase-iii-trial-of-denifanstat-asc40-a-first-in-class-once-daily-oral-fasn-inhibitor-for-acne-meets-all-endpoints-302472286.html
22 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/22/3086538/0/en/Sagimet-Biosciences-to-Host-Virtual-KOL-Event-Evaluating-the-Synergistic-Potential-of-a-Combination-of-Denifanstat-and-Resmetirom-for-the-Treatment-of-Metabolic-Dysfunction-Associa.html
12 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ascletis-completes-enrollment-of-phase-iii-trial-of-asc40-denifanstat-once-daily-oral-tablet-for-treatment-of-acne-302302294.html
16 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/16/2963912/0/en/Sagimet-Biosciences-Announces-Upcoming-Presentations-at-AASLD-The-Liver-Meeting-2024.html
Share 